Xlife Sciences AG (SWX:XLS)
Switzerland · Delayed Price · Currency is CHF 23.00
-1.40 (-5.74%)
Last updated: Mar 12, 2026, 4:40 PM CET
Xlife Sciences AG Market Cap
Xlife Sciences AG has a market cap or net worth of 140.73 million as of March 12, 2026. Its market cap has increased by 26.01% in one year.
Market Cap
140.73M
Enterprise Value
288.24M
Revenue
839.38K
Ranking
n/a
PE Ratio
5.37
Stock Price
23.00
Market Cap Chart
Since February 10, 2022, Xlife Sciences AG's market cap has decreased from 240.46M to 140.73M, a decrease of -41.48%. That is a compound annual growth rate of -12.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 140.73M | -1.21% |
| Dec 30, 2025 | 142.46M | -2.32% |
| Dec 30, 2024 | 145.84M | -47.72% |
| Dec 29, 2023 | 278.96M | 77.76% |
| Dec 30, 2022 | 156.93M | -34.74% |
| Feb 10, 2022 | 240.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 978.36M |
| Basilea Pharmaceutica AG | 649.00M |
| Newron Pharmaceuticals | 363.28M |
| Santhera Pharmaceuticals Holding AG | 237.31M |
| Molecular Partners AG | 140.25M |
| BioVersys AG | 135.09M |
| EvoNext Holdings | 6.35M |
| Addex Therapeutics | 5.25M |